On January 3, 2022 Emergent BioSolutions Inc. (NYSE: EBS) reported that members of the company’s executive management team will participate in the following investor conferences in the first quarter of 2022 (Press release, Emergent BioSolutions, JAN 3, 2022, View Source [SID1234597948]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

40th Annual J.P. Morgan Healthcare Conference
January 10 to 13, 2022
Company presentation scheduled on January 10 at 8:15 am PST
Click for Webcast
J.P. Morgan 2022 Global High Yield & Leveraged Finance Conference
February 28 to March 2, 2022
Company presentation scheduled on February 28 at 2:00 pm EST
Cowen & Co. 42nd Annual Health Care Conference
March 7 to 9, 2022
Presentation date and time will be updated on the Emergent website as the information becomes available
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company’s recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.